Almirall, S.A. (BME:ALM)
Spain · Delayed Price · Currency is EUR 10.36
-0.04 (-0.38%)
Oct 27, 2026, 11:47 AM CET
Almirall Market Cap
Almirall has a market cap or net worth of €2.26 billion as of October 26, 2026. It is the 5,692nd most valuable company in the world and the 44th biggest in Spain. Its market cap has decreased by 16.76% in one year.
Market Cap
2.26B
Enterprise Value
2.26B
Revenue
1.16B
Global Rank
Country Rank
#44 Spain
PE Ratio
37.49
ChartMarket Cap Chart
Since June 20, 2007, Almirall's market cap has decreased from 2.37B to 2.26B, a decrease of -4.86%. That is a compound annual growth rate of -0.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 2.26B | -18.19% |
| Dec 31, 2025 | 2.76B | 56.88% |
| Dec 31, 2024 | 1.76B | -0.35% |
| Dec 29, 2023 | 1.76B | 7.51% |
| Dec 30, 2022 | 1.64B | -19.23% |
| Dec 30, 2021 | 2.03B | 4.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.06B |
| Laboratorios Farmaceuticos Rovi | 3.08B |
| Faes Farma | 1.44B |
| Pharma Mar | 1.20B |
| Clínica Baviera | 862.58M |
| Prim, S.A. | 214.30M |
| Laboratorio Reig Jofre | 211.76M |
| Oryzon Genomics | 204.91M |